Abstract
Bone involvement in Hodgkin lymphoma (HL) is rare. The differential diagnosis between HL bone localization and other malignant or benign skeletal diseases is challenging. We report the case of a girl affected by classic HL, initially staged IVA because of supradiaphragmatic lymph nodes and skeletal involvement. After 6 ABVD (adriamycin, bleomycin, vinblastine, dacarbazine) cycles, positron emission tomography (PET) showed a complete metabolic response of the nodal localizations and a persistent, high metabolic activity of bone lesions. Salvage treatment followed by autologous stem cell transplant was carried out. After the transplant, the bone lesions maintained a high metabolic activity at PET. A targeted bone biopsy led to the diagnosis of a fibrous dysplasia excluding the presence of HL. To our knowledge, the concomitant presence of HL and fibrous dysplasia has not been previously reported. An in-depth evaluation of disease response to frontline treatment with a biopsy of the PET-hypercaptant bone lesions could have avoided overtreatment in this patient.
References
1.
Langley
CR
, Garrett
SJ
, Urand
J
, Kohler
J
, Clarke
NM
. Primary multifocal osseous Hodgkin’s lymphoma
. World J Surg Oncol
. 2008
Mar
;6
(1
):34
.
[PubMed]
1477-78192.
Feltl
D
, Markova
J
, Mocikova
H
, Dedeckova
K
, Kozak
T
. Prognostic impact of bone involvement in Hodgkin lymphoma
. Neoplasma
. 2008
;55
(2
):96
–100
.
[PubMed]
0028-26853.
Gaudio
F
, Pedote
P
, Niccoli Asabella
A
, Ingravallo
G
, Sindaco
P
, Alberotanza
V
, et al Bone involvement in Hodgkin’s lymphoma: clinical features and outcome
. Acta Haematol
. 2018
;140
(3
):178
–82
.
[PubMed]
0001-57924.
Georgi
TW
, Kluge
R
, Kurch
L
, Chavdarova
L
, Hasenclever
D
, Stoevesandt
D
, et al 18 F-FDG PET response of skeletal (bone marrow and bone) involvement after induction chemotherapy in pediatric Hodgkin lymphoma: are specific response criteria required?
J Nucl Med
. 2018
Oct
;59
(10
):1524
–30
.
[PubMed]
0161-55055.
Guermazi
A
, Brice
P
, de Kerviler E
E
, Fermé
C
, Hennequin
C
, Meignin
V
, et al Extranodal Hodgkin disease: spectrum of disease
. Radiographics
. 2001
Jan-Feb
;21
(1
):161
–79
.
[PubMed]
0271-53336.
Mohan
H
, Mittal
P
, Mundi
I
, Kumar
S
. Fibrous dysplasia of bone: a clinicopathologic review
. Pathol Lab Med Int
. 2011
;3
:31
–42
. 1179-26987.
Jour
G
, Oultache
A
, Sadowska
J
, Mitchell
T
, Healey
J
, Nafa
K
, et al GNAS mutations in fibrous dysplasia: a comparative study of standard sequencing and locked nucleic acid PCR sequencing on decalcified and non-decalcified formalin fixed paraffin embedded tissues
. Appl Immunohistochem Mol Morphol
. 2016
Oct
;24
(9
):660
–7
.
[PubMed]
1541-20168.
Ippolito
E
, Bray
EW
, Corsi
A
, De Maio
F
, Exner
UG
, Robey
PG
, et al; European Pediatric Orthopaedic Society
. Natural history and treatment of fibrous dysplasia of bone: a multicenter clinicopathologic study promoted by the European Pediatric Orthopaedic Society
. J Pediatr Orthop B
. 2003
May
;12
(3
):155
–77
.
[PubMed]
1060-152X9.
Shigesawa
T
, Sugawara
Y
, Shinohara
I
, Fujii
T
, Mochizuki
T
, Morishige
I
. Bone metastasis detected by FDG PET in a patient with breast cancer and fibrous dysplasia
. Clin Nucl Med
. 2005
Aug
;30
(8
):571
–3
.
[PubMed]
0363-976210.
Ho
KC
, Yen
TC
, Ng
SH
, Lin
KJ
. Mimicking extensive bone metastases in FDG-PET scan in an oral cancer patient with polyostotic fibrous dysplasia
. Ann Nucl Med Sci.
2006
;19
:247
–51
.11.
Kim
M
, Kim
HS
, Kim
JH
, Jang
JH
, Chung
KJ
, Shin
MK
, et al F-18 FDG PET-positive fibrous dysplasia in a patient with intestinal non-Hodgkin’s lymphoma
. Cancer Res Treat
. 2009
Sep
;41
(3
):171
–4
.
[PubMed]
1598-299812.
Mika
J
, Schleicher
I
, Gerlach
U
, Adler
CP
, Uhl
M
, Knoeller
SM
. Primary bone lymphomas thought to be osteomyelitis urgently demand a rapid diagnosis in bone pathology
. Anticancer Res
. 2012
Nov
;32
(11
):4905
–12
.
[PubMed]
1791-753013.
Charest
M
, Singnurkar
A
, Hickeson
M
, Novales
JA
, Derbekyan
V
. Intensity of FDG uptake is not everything: synchronous liposarcoma and fibrous dysplasia in the same patient on FDG PET-CT imaging
. Clin Nucl Med
. 2008
Jul
;33
(7
):455
–8
.
[PubMed]
0363-976214.
Suman Kc
S
, Sharma
P
, Singh
H
, Bal
C
, Kumar
R
. Fibrous dysplasia mimicking bone metastasis on both bone sintigraphy and 18-FDG PET-CT: diagnostic dilemma in a patient with breast cancer
. Nucl Med Mol Imaging
. 2012
Dec
;46
(4
):318
–9
.
[PubMed]
1869-347415.
Kim
J
, Chen
W
, Resnik
C
, Dilsizian
V
, Chen
Q
, Kimball
AS
. FDG uptake in liposclerosing myxofibrous tumor causes upstaging of Hodgkin lymphoma
. Clin Nucl Med
. 2015
Apr
;40
(4
):325
–7
.
[PubMed]
0363-976216.
Sun
X
, Lou
Y
, Wang
X
. The diagnosis of iliac bone destruction in children: 22 cases from two centres
. BioMed Res Int
. 2016
;2016
:2131859
.
[PubMed]
2314-613317.
Strauss
LG
. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients
. Eur J Nucl Med
. 1996
Oct
;23
(10
):1409
–15
.
[PubMed]
0340-699718.
Ostrowski
ML
, Inwards
CY
, Strickler
JG
, Witzig
TE
, Wenger
DE
, Unni
KK
. Osseous Hodgkin disease
. Cancer
. 1999
Mar
;85
(5
):1166
–78
.
[PubMed]
0008-543X19.
Lee
JS
, FitzGibbon
EJ
, Chen
YR
, Kim
HJ
, Lustig
LR
, Akintoye
SO
, et al Clinical guidelines for the management of craniofacial fibrous dysplasia
. Orphanet J Rare Dis
. 2012
May
;7
Suppl 1
:S2
.
[PubMed]
1750-117220.
Suleman
FE
, Bellew
N
. Primary bone lymphoma: imaging findings of a rare primary bone tumour
. SA Ortho J.
2011
;10
:68
–70
.21.
Jee
WH
, Choi
KH
, Choe
BY
, Park
JM
, Shinn
KS
. Fibrous dysplasia: MR imaging characteristics with radiopathologic correlation
. AJR Am J Roentgenol
. 1996
Dec
;167
(6
):1523
–7
.
[PubMed]
0361-803X22.
Riminucci
M
, Liu
B
, Corsi
A
, Shenker
A
, Spiegel
AM
, Robey
PG
, et al The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks
. J Pathol
. 1999
Jan
;187
(2
):249
–58
.
[PubMed]
0022-341723.
Dimitrakopoulou-Strauss
A
, Strauss
LG
, Heichel
T
, Wu
H
, Burger
C
, Bernd
L
, et al The role of quantitative (18)F-FDG PET studies for the differentiation of malignant and benign bone lesions
. J Nucl Med
. 2002
Apr
;43
(4
):510
–8
.
[PubMed]
0161-550524.
Lewis
J
, McCarten
K
, Kurch
L
, Flerlage
JE
, Kaste
SC
, Kluge
R
, et al Definition of cortical bone involvement in the staging of newly diagnosed pediatric Hodgkin lymphoma: A report from the International Working Group on Staging Evaluation and Response Criteria Harmonization (SEARCH)
. Pediatr Blood Cancer
. 2020
Apr
;67
(4
):e28142
.
[PubMed]
1545-5009© 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
